Penserra Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-7,217
| Closed | -$35K | – | 606 |
|
|
2017
Q1 | $35K | Buy |
7,217
+3,093
| +75% | +$15K | ﹤0.01% | 352 |
|
|
2016
Q4 | $45K | Buy |
4,124
+68
| +2% | +$742 | 0.01% | 406 |
|
|
2016
Q3 | $37K | Buy |
4,056
+1,014
| +33% | +$9.25K | ﹤0.01% | 380 |
|
|
2016
Q2 | $19K | Buy |
3,042
+369
| +14% | +$2.31K | ﹤0.01% | 479 |
|
|
2016
Q1 | $17 | Buy |
2,673
+891
| +50% | +$6 | ﹤0.01% | 466 |
|
|
2015
Q4 | $14K | Buy |
+1,782
| New | +$14K | ﹤0.01% | 471 |
|